Literature DB >> 35832109

The Role of Acupuncture for Long COVID: Mechanisms and Models.

James E Williams1, Jacques Moramarco1.   

Abstract

Objective: To establish an evidence-based role for acupuncture as a safe and effective treatment for managing Long COVID in the integrative medical setting. Background: COVID-19 progresses to a chronic state, termed Long COVID, in about 30% of cases with estimates as high as 40% for prolonged illness. Symptoms are diverse and range over several body systems, including unrelenting fatigue, persistent malaise, chronic pain, and mood changes. Early clinical reports suggest acupuncture can effectively address both symptoms and the underlying causes of Long COVID. Evidence: Historically, acupuncture is well defined in Traditional Chinese Medicine writings to treat influenza-like febrile illnesses. Contemporary scientific literature and case studies support the value of acupuncture for symptoms associated with acute and chronic respiratory viral infections, such as influenza, including SARS and COVID-19. Recent reports provide early evidence of acupuncture's effectiveness in managing Long COVID symptoms and may also have disease-modifying benefits.
Conclusion: Acupuncture is a viable adjunctive health care modality as part of a multidisciplinary approach for symptom control and disease management to improve quality of life in Long COVID patients. Since acupuncture may favorably modify the length and outcome of this condition, the model of acupuncture presented in this article warrants broader use in the integrative clinical setting and for further research. Copyright 2022, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  COVID-19; Long COVID; SARS-CoV-2; acupuncture; auricular acupuncture; long-haulers

Year:  2022        PMID: 35832109      PMCID: PMC9248327          DOI: 10.1089/acu.2021.0090

Source DB:  PubMed          Journal:  Med Acupunct        ISSN: 1933-6586


  41 in total

1.  An Auricular Marker for COVID-19.

Authors:  Nadia Volf; Valery Salques; Anne Lassaux
Journal:  Med Acupunct       Date:  2020-08-13

2.  Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19.

Authors:  Zeming Liu; Jinpeng Li; Danyang Chen; Rongfen Gao; Wen Zeng; Sichao Chen; Yihui Huang; Jianglong Huang; Wei Long; Man Li; Liang Guo; Xinghuan Wang; Xiaohui Wu
Journal:  Front Pharmacol       Date:  2020-07-17       Impact factor: 5.810

3.  Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis.

Authors:  George B Stefano; Pascal Büttiker; Simon Weissenberger; Anders Martin; Radek Ptacek; Richard M Kream
Journal:  Med Sci Monit       Date:  2021-05-10

Review 4.  Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2.

Authors:  Francesca Salamanna; Melania Maglio; Maria Paola Landini; Milena Fini
Journal:  Front Med (Lausanne)       Date:  2020-12-03

5.  Is IL-6 a key cytokine target for therapy in COVID-19?

Authors:  Simon A Jones; Christopher A Hunter
Journal:  Nat Rev Immunol       Date:  2021-04-13       Impact factor: 53.106

6.  Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response.

Authors:  Liam Townsend; Helen Fogarty; Adam Dyer; Ignacio Martin-Loeches; Ciaran Bannan; Parthiban Nadarajan; Colm Bergin; Cliona O'Farrelly; Niall Conlon; Nollaig M Bourke; Soracha E Ward; Mary Byrne; Kevin Ryan; Niamh O'Connell; Jamie M O'Sullivan; Cliona Ni Cheallaigh; James S O'Donnell
Journal:  J Thromb Haemost       Date:  2021-03-08       Impact factor: 16.036

Review 7.  Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy.

Authors:  Emma C Morris; Sattva S Neelapu; Theodoros Giavridis; Michel Sadelain
Journal:  Nat Rev Immunol       Date:  2021-05-17       Impact factor: 53.106

8.  Long-term clinical and biochemical residue after COVID-19 recovery.

Authors:  Mohammed Ali Gameil; Rehab Elsayed Marzouk; Ahmed Hassan Elsebaie; Salah Eldeen Rozaik
Journal:  Egypt Liver J       Date:  2021-09-12

9.  Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.

Authors:  Hannah E Davis; Gina S Assaf; Lisa McCorkell; Hannah Wei; Ryan J Low; Yochai Re'em; Signe Redfield; Jared P Austin; Athena Akrami
Journal:  EClinicalMedicine       Date:  2021-07-15

Review 10.  Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.

Authors:  Anne M Davidson; Jan Wysocki; Daniel Batlle
Journal:  Hypertension       Date:  2020-08-27       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.